Cooperation with the Leibniz Institute for Agricultural Engineering and Bioeconomy
Berlin / Lucerne, August 16, 2023 - Prof. Dr. Christine Lang, Chief Research and Development Officer of BELANO medical AG, has been appointed to the scientific advisory board of Cerefort GmbH. The company, based in the Swiss canton of Nidwalden, develops fermentatively produced beverages with health-promoting effects. To this end, it also collaborates with the fermentation working group of the Leibniz Institute of Agricultural Engineering and Bioeconomics (ATB), which researches, among other things, the use and effect of lactic acid and lactic acid production.
In this context there was a positive effect on the integrity and function of mitochondria proven for an acidic fermented D-lactate-containing soft drink from Cerefort. These mitochondria are the primary source of metabolic energy. Vitality and well-being may therefore depend on their function.
BELANO medical has been researching lactic acid bacteria by screening in its own laboratory for many years and uses their natural biological effect on the human microbiome, for example, for the development of alternative medical skin care or other medical products. Among other things, they are used to treat neurodermatitis, inflammations such as Helicobacter pylori, inflammations in the mouth and throat such as periodontosis or throat diseases, and as an active ingredient against multi-resistant germs (MRSA). Christine Lang is also Professor of Microbiology and Molecular Genetics at the Technical University of Berlin. From 2012 to 2019, she was Chair of the Bioeconomy Council of the German Federal Government.